Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$21.33 - $59.42 $386,734 - $1.08 Million
18,131 New
18,131 $415,000
Q4 2021

Feb 17, 2022

SELL
$43.27 - $65.72 $395,877 - $601,272
-9,149 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$53.61 - $67.5 $237,813 - $299,430
4,436 Added 94.12%
9,149 $518,000
Q2 2021

Sep 17, 2021

BUY
$45.13 - $64.99 $212,697 - $306,297
4,713 New
4,713 $270,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.